Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
Genetic cloning and sequencing of a novel IL-17 receptor-related gene More
Biomimic prenatal and postnatal maternal-to-infant transfer of clinical monosaccharides for improved neurologic development and immunologic functions More
New methods of diagnosing and monitoring the progression or response to therapy of subjects with autoimmune hepatitis More
Methods, systems and transgenic animals useful for screening, diagnosing and treating FUS1 related disorders More
Novel compositions and methods for delivering inhibitory oligonucleotides to cells in a targeted and efficient manner have been developed. More
MGD3 monoclonal antibody binds human Dectin-1 with high affinity and regulates production of cytokines TNF-α and Interleukin-10. MGD3 has a potential therapeutic use on inflammatory diseases. More
Novel agents that can interfere with the action of nuclear hormone receptors More
We have shown that measurement of anti-CD38 IgG antibodies in plasma or in peripheral blood mononuclear cells (including lymphocytes T) is applicable to diagnosis and prognosis of systemic lupus erythematosus More
Development of Drug for Vitiligo Treatment Using Histamine More
Related Reports
Market Research Reports provided by reports.innovaro.com
May 2011 - 15 pages - $250
Jan 2010 - $75
Dec 2010 - 37 pages - $500
Jan 2010 - $75
Jul 2011 - 39 pages - $5,700
Jan 2011 - 34 pages - $500
Nov 2010 - 40 pages - $500
Feb 2011 - 42 pages - $5,700
Feb 2012 - 1350 pages - $2,695
May 2011 - 15 pages - $250
Your selection
Browse By
- Industry sector
- Antibody-based diagnostics
- Biomarker-based diagnostics
- CAT
- Genetic diagnostics
- Imaging
- MRI
- Nuclear medicine
- Other
- Self-test systems
- Supplies
- Test systems
- Ultrasound
- X-ray
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us